摘要 |
Compounds of formula (I), wherein R1 and R2 are each independently hydrogen, halogen, (C1-C7)alkyl, (C1-C7)alkoxy, trifluoromethyl; R3 is (C1-C7)alkyl, (C3-C7)cycloalkyl; cyclohexyl, cyclohexylmethyl, phenyl, benzyl; R4 is azido, a 2,2-dimethylhydrazino group; (C1-C7)alkylsulfonamido; phenylsulfonamido, dimethylaminosulfonamido, a NR7R8 group; a NR9R10 group; a NR9R11 group; a R12 heterocyclic radical, piperazin-1-yl; a lactoylamino group, a mandeloylamino group; a N'-(1-phenylethyl)ureido group; a N'-(1-naphth-1-ylethyl)ureido group; R5 is hydrogen or one of the values assigned to R6; R6 is halogen; (C1-C7)alkyl, trifluoromethyl, cyano, aminomethyl, nitro, an NR9R11 group; a heterocyclic radical selected from pyrrol-1-yl, DELTA 3-pyrrolin-1-yl, pyrrolidin-1-yl, morpholin-4-yl; an OR13 group; a SR13 group; guanidino, formyl, (C1-C7)alkylcarbonyl, carbamoyl; thiocarbamoyl, sulfamoyl, carboxy, (C1-C7)alkoxycarbonyl; phenoxycarbonyl, benzyloxycarbonyl, (C1-C7)alkylsulfonamido, phenylsulfonamido, dimethylaminosulfonamido, 2-(4methylphenyl)benzamido; or R5 and R6 together with the phenyl to which they are attached form a group (a); provided that X is -SO2-; X is SO2; CH2. The compounds of the invention have an affinity for vasopressin and/or ocytocine receptors. |
申请人 |
SANOFI;WAGNON, JEAN;TONNERRE, BERNARD;DI MALTA, ALAIN;ROUX, RICHARD;AMIEL, MARIE-SOPHIE;SERRADEIL-LEGAL, CLAUDINE |
发明人 |
WAGNON, JEAN;TONNERRE, BERNARD;DI MALTA, ALAIN;ROUX, RICHARD;AMIEL, MARIE-SOPHIE;SERRADEIL-LEGAL, CLAUDINE |